Resources center summary
Proton Therapy Publication
May 2023
Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.
Link to the fully detailed content
Proton Therapy Publication
March 2023
Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2022
Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2022
Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
June 2022
Dose-escalated PT with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
December 2021
FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification.
Link to the fully detailed content
User meeting
November 18, 2021
Show&Tell #4: Gastrointestinal cancers
Michael
Chuong
Tae Hyun
Kim
Andrew
Wroe
Adeel
Kaiser
Please connect to access this resource and get a more personalized Campus experience
Link to the log in page
Proton Therapy Publication
Proton therapy publication
October 2021
Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2021
Assessing concordance between patient-reported and investigator-reported CTCAE after PBT for prostate cancer.
Link to the fully detailed content